Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Clinical Evaluation of the Cinatra™ Corolimus-Eluting Coronary Stent in De Novo Lesions in Native Coronary Arteries (VANTAGE-1)

This study has been terminated.
(Terminated following completion of 2 year time point: Sponsor decision)
Information provided by (Responsible Party):
Atrium Medical Corporation Identifier:
First received: December 3, 2009
Last updated: January 8, 2016
Last verified: January 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2012
  Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)